Results 261 to 270 of about 10,746,438 (360)
Newborn screening for sickle cell disease in Caluquembe, southwestern Angola, 2024-2025. [PDF]
Su JJ +3 more
europepmc +1 more source
ABSTRACT This study isolated a compound with anti‐inflammatory properties from Musa × paradisiaca fruit peels. The methanol extract was partitioned, and the hexane fraction with the best bioactivity was subjected to column chromatography before characterization via Fourier transform infrared (FTIR), UV–visible (UV–VIS) and NMR analysis.
Ibeabuchi J. Ali +7 more
wiley +1 more source
Acoustic probing of new biomarkers for rapid sickle cell disease screening.
Sridhar N +4 more
europepmc +1 more source
Association between sickle cell anaemia and dental caries among children in Nigeria. [PDF]
Afolabi JB +5 more
europepmc +1 more source
Protein Z is a vitamin K‐dependent anticoagulant with elusive molecular functions. Herein, it is shown that heme binds to protein Z and induces conformational changes. One histidine‐based heme‐binding motif is identified. High heme‐binding affinity and functional effects are demonstrated on protein level. These findings shed new light on the structural
Paula Lindemann, Marie‐T. Hopp
wiley +1 more source
Burden of sickle cell anemia in Africa: A systematic review and meta-analysis. [PDF]
Jonani B +9 more
europepmc +1 more source
ABSTRACT An 8‐year‐old immunocompromised girl with a large septic wound on the left thigh was admitted to the facility after the failure of home treatment by the family. The child was generally stable aside from the difficulty in walking on the left leg.
Matilda Mawusi Kodjo +5 more
wiley +1 more source
The investigational agent osivelotor, a small molecule hemoglobin (Hb) modifier in development for the treatment of sickle cell disease (SCD), acts by increasing Hb‐oxygen affinity and inhibiting the polymerization of sickle Hb. We report safety, pharmacokinetic (PK), and pharmacodynamic (PD) data from the first two phase 1 clinical trials of ...
Eleanor A. Lisbon +15 more
wiley +1 more source
Building a Comprehensive Sickle Cell Disease Program in Western Kenya: A Decade of Experience and Growth. [PDF]
Njuguna F +18 more
europepmc +1 more source

